Complete Revascularization Versus Culprit Lesion Only PCI in NSTEMI
NCT ID: NCT05786131
Last Updated: 2025-01-16
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
3390 participants
INTERVENTIONAL
2023-10-27
2027-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Physiology-guided vs Angiography-guided Non-culprit Lesion Complete Revascularization for Acute MI & Multivessel Disease
NCT05701358
Prospective Global Registry for the Study of Chronic Total Occlusion Intervention
NCT02061436
PRospective Evaluation of Complete Revascularization in Patients With multiveSsel Disease Excluding chroNic Total Occlusions
NCT05230446
Impact of Rotational Atherectomy on Coronary Microcirculation
NCT05771961
The COMPLETE Study
NCT06205810
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
culprit-lesion-only revascularization
Patients will receive optimal medical therapy without further revascularization of non-culprit lesions (neither during index hospitalization nor during follow-up). Angina pectoris will be treated medically as recommended in the chronic coronary syndrome guidelines. Revascularization of non-culprit lesions will only be permitted if at least one bailout criteria is met.
Culprit-lesion revascularization
Percutaneous coronary intervention of culprit-lesion
multivessel complete revascularization
Patients will receive complete revascularization of all angiographically significant non-culprit lesions, either during the index procedure, the index hospitalization, or staged within 45 days after PCI of the culprit lesion.
Culprit-lesion revascularization
Percutaneous coronary intervention of culprit-lesion
Non-culprit-lesion revascularization
Complete percutaneous coronary intervention of all angiographically significant non-culprit lesions
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Culprit-lesion revascularization
Percutaneous coronary intervention of culprit-lesion
Non-culprit-lesion revascularization
Complete percutaneous coronary intervention of all angiographically significant non-culprit lesions
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Multivessel coronary artery disease
* Identifiable culprit lesion
* Informed consent
Exclusion Criteria
* Cardiogenic shock
* Sustained ventricular tachycardia (VT) or ventricular fibrillation (VF)
* Contraindication for coronary revascularization
* Prior coronary artery bypass graft
* Indication for coronary artery bypass graft surgery
* Non-culprit lesion located in the left main coronary artery
* Co-morbidity with life expectancy less than 6 months
* Type 2 myocardial infarction
* Pregnancy and breast feeding period
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Heart Center Leipzig at University of Leipzig
UNKNOWN
German Federal Ministry of Education and Research
OTHER_GOV
IHF GmbH - Institut für Herzinfarktforschung
OTHER
Stiftung IHF - Institut für Herzinfarktforschung
UNKNOWN
Leipzig Heart Science gGmbH
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Holger Thiele, MD, Prof. Dr.
Role: STUDY_CHAIR
Heart Center Leipzig at University of Leipzig, Department of Internal Medicine/Cardiology
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
LKH Univ. Klinikum Graz, Clinical Department of Cardiology
Graz, , Austria
Medizinische Universität Innsbruck, Universitätsklinik für Innere Medizin III
Innsbruck, , Austria
Klinik Ottakring, 3. medizinische Abteilung
Vienna, , Austria
Zentralklinik Bad Berka, Klinik für Kardiologie
Bad Berka, , Germany
Universitäts-Herzzentrum Bad Krozingen, Klinik für Kardiologie und Angiologie
Bad Krozingen, , Germany
Kerckhoff Klinik
Bad Nauheim, , Germany
Herz- und Diabeteszentrum NRW, Universitätsklinikum der Ruhr-Universität Bochum, Klinik für Allgemeine und Interventionelle Kardiologie/Angiologie
Bad Oeynhausen, , Germany
BG Klinikum Unfallkrankenhaus Berlin gGmbH, Klinik für Innere Medizin/Kardiologie
Berlin, , Germany
Charité - University Medicine Berlin, Department of Internal Medicine and Cardiology, Campus Virchow Klinikum
Berlin, , Germany
Klinikum Bielefeld gem. GmbH, Klinik für Kardiologie und Internistische Intensivmedizin
Bielefeld, , Germany
Klinik für Kardiologie und Rhythmologie, St. Josef Hospital, Universitätsklinikmum der Ruhr-Universität Bochum
Bochum, , Germany
Klinikum Links der Weser, Innere Medizin II
Bremen, , Germany
Städtisches Klinikum Dessau; Klinik für Innere Medizin II (Kardiologie, Angiologie, Diabetologie, internistische Intensivmedizin)
Dessau, , Germany
St. Johannes Hospital, Klinik für Innere Medizin I
Dortmund, , Germany
Herzzentrum Dresden GmbH, Universitätsklinik an der Technischen Universität Dresden, Klinik für Innere Medizin und Kardiologie
Dresden, , Germany
Heinrich Heine Universitätsklinikum Düsseldorf Institut für Kardiologie, Pneumologie und Angiologie
Düsseldorf, , Germany
HELIOS Klinikum Erfurt, Medizinische Klinik III - Kardiologie
Erfurt, , Germany
Universitätsklinikum Erlangen, Medizinische Klinik 2
Erlangen, , Germany
Elisabeth Krankenhaus Essen, Klinik für Kardiologie und Angiologie
Essen, , Germany
Universitätsklinikum Essen, Klinik für Kardiologie und Angiologie
Essen, , Germany
Universitätsklinikum Freiburg, Klinik für Kardiologie und Angiologie
Freiburg im Breisgau, , Germany
Klinikum Fulda, Medizinischen Klinik 1 - Kardiologie, Angiologie und Intensivmedizin
Fulda, , Germany
Universitätsklinikum Gießen und Marburg GmbH, Medizinische Klinik I, Kardiologie
Giessen, , Germany
University Medical Center Göttingen, Department of Cardiology and Pneumology, Georg-August University
Göttingen, , Germany
Universitätsmedizin Greifswald, Klinik und Poliklinik für Innere Medizin B
Greifswald, , Germany
Universitätsklinikum Halle (Saale), Klinik für Innere Medizin III
Halle, , Germany
Asklepios Klinik St. Georg, Kardiologie und Internistische Intensivmedizin
Hamburg, , Germany
Universitäres Herz- und Gefäßzentrum UKE Hamburg GmbH, Klinik für Kardiologie
Hamburg, , Germany
Asklepios Klinik Altona
Hamburg, , Germany
Klinik für Kardiologie, Angiologie und Pneumologie, Medizinische Klinik 3, Universitätsklinikum Heidelberg
Heidelberg, , Germany
Universitätsklinikum des Saarlandes, Klinik für Innere Medizin II
Homburg, , Germany
Universitätsklinikum Jena, Klinik für Innere Medizin I, Kardiologie, Angiologie, Internistische Intensivmedizin
Jena, , Germany
Vincentius-Diakonissen-Kliniken gAG Medizinische Klinik III, Kardiologie, Intensivmedizin, Angiologie
Karlsruhe, , Germany
Universitätsklinikum Schleswig-Holstein, Campus Kiel, Klinik für Innere Medizin III mit den Schwerpunkten Kardiologie und internistische Intensivmedizin
Kiel, , Germany
Asklepios Klinik Langen, Abteilung Medizinische Klinik I
Langen, , Germany
Universitätsklinikum Leipzig, Klinik und Poliklinik für Kardiologie
Leipzig, , Germany
Klinikum St. Georg gGmbH Klinik für Kardiologie und Internistische Intensivmedizin
Leipzig, , Germany
Heart Center Leipzig at University of Leipzig, Department of Internal Medicine/Cardiology
Leipzig, , Germany
Klinikum der Stadt Ludwigshafen, Medizinische B Klinik
Ludwigshafen, , Germany
Universitätsklinikum Schleswig Holstein, Medizinische Klinik II, Campus Lübeck
Lübeck, , Germany
Universitätsklinikum Magdeburg, Klinik für Kardiologie und Angiologie
Magdeburg, , Germany
Brüderklinikum Julia Lanz, Theresienkrankenhaus
Mannheim, , Germany
Universitätsmedizin Mannheim, I. Medizinische Klinik, Kardiologie, Angiologie, Hämostaseologie und Internistische Intensivmedizin
Mannheim, , Germany
Universitätsklinikum Gießen und Marburg GmbH - Standort Marburg, Klinik für Innere Medizin - Kardiologie, Angiologie und Intensivmedizin
Marburg, , Germany
Klinikum der Universität München, Medizinische Klinik und Poliklinik I
München, , Germany
Deutsches Herzzentrum München, Klinik für Herz- und Kreislauferkrankungen
München, , Germany
Klinikum Neumarkt
Neumarkt, , Germany
Klinikum Nürnberg, Medizinische Klinik 8 - Schwerpunkt Kardiologie, Universitätsklinik der Paracelsus Medizinischen Privatuniversität
Nuremberg, , Germany
Universitätsklinik für Kardiologie am Klinikum Oldenburg
Oldenburg, , Germany
Helios Vogtland-Klinikum Plauen
Plauen, , Germany
Universitätsklinikum Regensburg, Klinik und Poliklinik für Innere Medizin II
Regensburg, , Germany
Universitätsmedizin Rostock, Zentrum für Innere Medizin, Abteilung für Kardiologie
Rostock, , Germany
Helios Kliniken Schwerin, Klinik für Kardiologie und Angiologie
Schwerin, , Germany
Krankenhaus der Barmherzigen Brüder Trier, Herzzentrum Innere Medizin III - Kardiologie
Trier, , Germany
Universitätsklinikum Tübingen, Medizinische Klinik, Innere Medizin III, Kardiologie und Angiologie
Tübingen, , Germany
Schwarzwald-Baar Klinikum VS, Studienteam Kardiologie
Villingen-Schwenningen, , Germany
Städtisches Klinikum Wolfenbüttel gGmbH, Klinik für Innere Medizin - Kardiologie,
Wolfenbüttel, , Germany
Helios Klinikum Wuppertal, Herzkreislaufforschung
Wuppertal, , Germany
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Gabor Thoth-Gayor, MD
Role: primary
Sebastian Reinstadler, MD
Role: primary
Alexander Geppert, MD
Role: primary
Philipp Lauten, MD
Role: primary
Miroslaw Ferenc, MD
Role: primary
Maren Weferling, MD
Role: primary
Regine Brinkmann, MD
Role: primary
Sebastian Winkler, MD
Role: primary
Tobias Trippel, MD
Role: primary
Christoph Stellbrink, MD
Role: primary
Arash Haghikia, MD
Role: primary
Harm Wienbergen, MD
Role: primary
Georg Fürnau, MD
Role: primary
Helge Möllmann, MD
Role: primary
Axel Linke, MD
Role: primary
Christian Jung, MD
Role: primary
Alexander Lauten, MD
Role: primary
Stephan Achenbach, MD
Role: primary
Thomas Schmitz, MD
Role: primary
Tienush Rassaf, MD
Role: primary
Christoph Oliver, MD
Role: primary
Volker Schächinger, MD
Role: primary
Samuel Sossalla, MD
Role: primary
Karl Toischer, MD, Prof.
Role: primary
Marcus Dörr, MD
Role: primary
Daniel Sedding, MD
Role: primary
Eike Tigges, MD
Role: primary
Peter Clemmensen, MD
Role: primary
Felix Meincke, MD
Role: primary
Haitham Abu Sharar, MD
Role: primary
Saarraangan Kulenthiran, MD
Role: primary
Christian Schulze, MD
Role: primary
Claudius Jacobshagen, MD
Role: primary
Derk Frank, MD
Role: primary
Ralf Lehmann, MD
Role: primary
Christian Spies, MD
Role: primary
Norbert Klein, MD
Role: primary
Ralf Zahn, MD
Role: primary
Ingo Eitel, MD
Role: primary
Alexander Schmeisser, MD
Role: primary
Ramon Tschierschke, MD
Role: primary
Ibrahim Akin, MD
Role: primary
Georgios Chatzis, MD
Role: primary
Konstaninos Rizas, MD
Role: primary
Adnan Kastrati, MD
Role: primary
Ulrich Reiser, MD
Role: primary
Fadil Ademaj, MD
Role: primary
Albrecht Elsässer, MD
Role: primary
Christian Bietau, MD
Role: primary
Lars Maier, MD
Role: primary
Alper Öner, MD
Role: primary
Alexander Staudt, MD
Role: primary
Nikos Werner, MD
Role: primary
Tobias Geisler, MD
Role: primary
Sebastian Ewen, MD
Role: primary
Björn Billmann, MD
Role: primary
Melchior Seyfarth, MD
Role: primary
References
Explore related publications, articles, or registry entries linked to this study.
Feistritzer HJ, Jobs A, Zeymer U, Schneider S, Lauten P, Ferenc M, Weferling M, Brinkmann R, Winkler S, Landmesser U, Trippel T, Stellbrink C, Wienbergen H, Furnau G, Mollmann H, Linke A, Jung C, Lauten A, Achenbach S, Rassaf T, Schmitz T, Cremer S, Olivier C, Schachinger V, Sossalla S, Toischer K, Templin C, Sedding D, Clemmensen P, Tigges E, Meincke F, Sharar HA, Kulenthiran S, Schulze PC, Jacobshagen C, Frank D, Baldus S, Lehmann R, Spies C, Klein N, Eitel I, Zahn R, Schmeisser A, Gori T, Lurz P, Akin I, Chatzis G, Rizas K, Kessler T, Ademaj F, Elsasser A, Maier L, Oner A, Staudt A, Werner N, Geisler T, Kessler M, Ferrari MW, Seyfarth M, Nordbeck P, Ewen S, Bietau C, Haghikia A, Reinstadler SJ, Geppert A, Hosler N, Toth-Gayor G, Billmann B, Tschierschke R, Schmidt C, Fichtlscherer S, Thiele H; COMPLETE-NSTEMI Investigators. Complete revascularization versus culprit-lesion only PCI in patients with NSTEMI and multivessel disease - Design and rationale of the randomized COMPLETE-NSTEMI trial. Am Heart J. 2025 Sep;287:94-106. doi: 10.1016/j.ahj.2025.04.007. Epub 2025 Apr 8.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2023-019
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.